Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CARE RatingsBOM:534804 +1.00%81 PS Ratio is 11.12 as of Aug. 08, 2026, which is 28% above its 10-year median of 8.69. GuruFocus rates BOM:534804 with a GF Score™ of 81/100 and a GF Value™ of ₹1,709.11 (Fairly Valued). The stock has 1 warning sign investors should review. Among 756 Capital Markets companies, CARE Ratings ranks worse than 77.65% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, CARE Ratings's share price is ₹1746.10.
CARE Ratings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹156.96. Hence, CARE Ratings's PS Ratio for today is 11.12.
The historical rank and industry rank for CARE Ratings's PS Ratio or its related term are showing as below:
BOM:534804'
s PS Ratio Range Over the Past 10 Years
Min: 3.38 Med: 8.69 Max: 76.88
Current: 10.85
During the past 13 years, CARE Ratings's highest PS Ratio was 76.88. The lowest was 3.38. And the median was 8.69.
BOM:534804's PS Ratio is ranked worse than 77.65% of 756
companies
in the Capital Markets industry
Industry Median: 4.125
vs BOM:534804: 10.85
During the past 12 months, the average Revenue per Share Growth Rate of CARE Ratings was 17.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 18.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 14.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.20% per year.
During the past 13 years, CARE Ratings's highest 3-Year average Revenue per Share Growth Rate was 18.60% per year. The lowest was -9.00% per year. And the median was 7.00% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
CARE Ratings PS Ratio Related Terms
CARE Ratings PS Ratio Historical Data
* Premium members only.
The historical data trend for CARE Ratings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Financial Data & Stock Exchanges subindustry, CARE Ratings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CARE Ratings PS Ratio vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CARE Ratings's PS Ratio distribution charts can be found below:
* The bar in red indicates where CARE Ratings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
CARE Ratings's PS Ratio for today is calculated as
CARE Ratings's Share Price of today is ₹1746.10. CARE Ratings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹156.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
CARE Ratings (BOM:534804) has a PS Ratio of 11.12 as of Aug. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on CARE Ratings and its competitors. This is 28% above median its historical median of 8.69. Over the past decade, CARE Ratings' PS Ratio has ranged from 3.38 to 76.88. According to the industry distribution chart, CARE Ratings ranks #587 out of 756 companies in the Capital Markets industry, placing it in the top 77.6%.
Is CARE Ratings' PS Ratio too high?
CARE Ratings' current PS Ratio of 11.12 is 28% above median its 10-year median of 8.69. Over the past 10 years, this metric has ranged from a low of 3.38 to a high of 76.88. The Capital Markets industry median PS Ratio is 4.13. CARE Ratings' value of 11.12 is 169.6% above this industry median. Based on the distribution chart, CARE Ratings ranks #587 out of 756 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, CARE Ratings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CARE Ratings' PS Ratio compare to SPGI and CME?
According to the Capital Markets industry distribution chart, CARE Ratings ranks #587 out of 756 companies for PS Ratio. This places CARE Ratings in the lower half of its industry. The industry median PS Ratio is 4.13. CARE Ratings' value of 11.12 is 169.6% above this benchmark. Historically, CARE Ratings' own PS Ratio has ranged from 3.38 to 76.88 over the past decade. While the company's 10-year median is 8.69 vs. the industry median of 4.13, CARE Ratings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Capital Markets company?
The median PS Ratio among Capital Markets companies is 4.13, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CARE Ratings's current PS Ratio of 11.12 is 169.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on CARE Ratings and its competitors. For the Capital Markets industry, the median PS Ratio is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CARE Ratings's current PS Ratio is 11.12, which is 28% above median its own 10-year median of 8.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARE Ratings stock overvalued right now?
Based on GuruFocus' analysis, CARE Ratings (BOM:534804) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,709.11, compared to a current price of ₹1,746.10 — trading 2.2% above its estimated fair value. The current PS Ratio is 11.12, which is 28% above median its 10-year median of 8.69 and 169.6% above the Capital Markets industry median of 4.13. CARE Ratings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For CARE Ratings (BOM:534804), the current PS Ratio is 11.12 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CARE Ratings (BOM:534804) Overvalued in 2026?
Based on GuruFocus' analysis, CARE Ratings stock appears to be overvalued.
The current stock price of ₹1,746.10 is trading 2.2% above its estimated GF Value™ of ₹1,709.11.
GuruFocus considers CARE Ratings to be Fairly Valued.
Key valuation signals for BOM:534804:
PS Ratio: 11.12 (28% above median its 10-year median of 8.69)
GF Value™: ₹1,709.11 vs. price of ₹1,746.10 (2.2% above fair value)
Industry Position: 169.6% above the Capital Markets median (#587 of 756)
No single metric tells the full story. See the BOM:534804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
81GF Score
Get the complete analysis for BOM:534804
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:534804 has been successfully added to your 
